Published in Am J Ophthalmol on April 29, 2014
Recent advances in diagnosis and management of Mycotic Keratitis. Indian J Ophthalmol (2016) 0.87
In vitro combination therapy using low dose clotrimazole and photodynamic therapy leads to enhanced killing of the dermatophyte Trichophyton rubrum. BMC Microbiol (2014) 0.77
Evaluation of the Effects of Photodynamic Therapy Alone and Combined with Standard Antifungal Therapy on Planktonic Cells and Biofilms of Fusarium spp. and Exophiala spp. Front Microbiol (2016) 0.76
Review of clinical and basic approaches of fungal keratitis. Int J Ophthalmol (2016) 0.75
Chlorin e6 mediated photodynamic inactivation for multidrug resistant Pseudomonas aeruginosa keratitis in mice in vivo. Sci Rep (2017) 0.75
Rose Bengal Photodynamic Antimicrobial Therapy: A Novel Treatment for Resistant Fusarium Keratitis. Cornea (2017) 0.75
Rose Bengal-Green Light for Collagen Cross-linking. J Ophthalmic Vis Res (2017) 0.75
Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol (2003) 8.29
Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci (2004) 4.60
The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea (2002) 3.25
UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol (2011) 2.57
Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother (2005) 1.89
Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J Antimicrob Chemother (2002) 1.87
Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett (1998) 1.54
Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefes Arch Clin Exp Ophthalmol (2009) 1.53
Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci (2008) 1.51
Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology (2010) 1.30
Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology (2010) 1.30
Fungal keratitis in London: microbiological and clinical evaluation. Cornea (2007) 1.21
Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Proc Natl Acad Sci U S A (1993) 1.19
In vitro effects of photodynamic therapy on Aspergillus fumigatus. J Antimicrob Chemother (2001) 1.18
Photodynamic therapy of age-related macular degeneration: History and principles. Semin Ophthalmol (2001) 1.10
What is actually stained by rose bengal? Arch Ophthalmol (1992) 1.08
Killing of methicillin-resistant Staphylococcus aureus by low-power laser light. J Med Microbiol (1995) 1.08
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol (2012) 1.07
The role of oxygen radicals in dye-mediated photodynamic effects in Escherichia coli B. J Biol Chem (1987) 1.06
All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence (2011) 1.05
Diagnostic and therapeutic considerations in fungal keratitis. Int Ophthalmol Clin (2011) 1.02
The cytotoxic and photodynamic inactivation of micro-organisms by Rose Bengal. J Appl Bacteriol (1985) 1.01
Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg (2012) 0.98
The effects of rose bengal- and erythrosine-mediated photodynamic therapy on Candida albicans. Mycoses (2011) 0.96
Collagen cross-linking using rose bengal and green light to increase corneal stiffness. Invest Ophthalmol Vis Sci (2013) 0.96
Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am J Ophthalmol (2011) 0.94
Fungal, Mycobacterial, and Nocardia infections and the eye: an update. Eye (Lond) (2011) 0.91
Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration. Graefes Arch Clin Exp Ophthalmol (2012) 0.87
Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether. Am J Ophthalmol (2006) 0.86
Photodecontamination of blood components: advantages and drawbacks. Clin Hemorheol Microcirc (1998) 0.85
Effect of glutathione on rose bengal photosensitized yeast damage. Microbios (1993) 0.84
The effect of photodynamic treatment of yeast with the sensitizer chloroaluminum phthalocyanine on various cellular parameters. Photochem Photobiol (1995) 0.83
Protective effect of amphotericin B against lethal photodynamic treatment in yeast. Microbios (1995) 0.82
Photodynamic therapy for ocular tumors. J Photochem Photobiol B (1991) 0.77